Genpharmasec Ltd — Board Meeting, 07-08-2025: Board Meeting

Genpharmasec Limited's Board of Directors has approved the standalone and consolidated financial results for the quarter ended June 30, 2025. The company reported standalone revenue from operations of 12.11 Cr with a profit after tax of 1.56 Cr. On a consolidated basis, revenue from operations stood at 12.04 Cr, with a profit after tax of 1.22 Cr. These results, reviewed by the Audit Committee, offer a clear view of the company's recent financial performance, crucial for investors tracking its operational health.